X. Long Zheng: Novel Gain-of-Function ADAMTS13 Variant with Potential Therapeutic Impact
X. Long Zheng, Professor and Chair of Pathology and Laboratory Medicine at The University of Kansas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Hot off the press in the Journal of Thrombosis and Haemostasis (JTH) from Szumam Liu et al. about a novel gain-of-funtion ADAMTS13 variant that may have therapeutic implications.
Thank you all for your hardworking and close collaboration.”
Title: ADAMTS13 R1206K Variant Exhibits an Open Conformation and Enhanced Proteolytic Activity toward von Willebrand factor
Authors: Szumam Liu, Xiaxin Dong, Quintijn Bonnez, Zhirong Chai, Chan Meng, Madison Gil, Karen Vanhoorelbeke, Konstantine Halkidis, X. Long Zheng
Read the Full Article on Journal of Thrombosis and Haemostasis
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 24, 2026, 09:29Advancing Women’s Health Through Collaboration with Jean Hailes for Women’s Health – Stroke Foundation
-
Jun 24, 2026, 09:18The Lasting Immunological Footprint of VITT – JTH
-
Jun 24, 2026, 09:09Umberto Pensato: Dedicated Funding Pathways for Stroke Research in Italy
-
Jun 24, 2026, 09:00Danny Gaskin: BBTS 2026 and the Evolving Role of Transfusion in Maternity Care
-
Jun 24, 2026, 07:46Wolfgang Miesbach: WFH’s First AAV Gene Therapy Chapter Marks a New Era in Hemophilia Care
-
Jun 24, 2026, 06:42Deepthi Krishna: World Blood Donor Day 2026 Celebrations at Rela Hospital
-
Jun 24, 2026, 03:36Ana Pedrero Gil: A New Approach to Post-Tonsillectomy Hemorrhage
-
Jun 24, 2026, 02:59Melissa Hollo: Making Early Anemia Detection the Standard of Care
-
Jun 24, 2026, 02:51Bruno Pougault: The Thin Line Between Bleeding and Clotting